Cargando…
The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation
Background The benefit of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) on major bleeding was less prominent among atrial fibrillation (AF) patients with polypharmacy in post-hoc randomized controlled trials analyses. Whether this phenomenon also exists in routine care is u...
Autores principales: | van den Dries, Carline J., van Doorn, Sander, Souverein, Patrick, Pajouheshnia, Romin, Moons, Karel G.M., Hoes, Arno W., Geersing, Geert-Jan, van den Ham, Hendrika A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758151/ https://www.ncbi.nlm.nih.gov/pubmed/33376941 http://dx.doi.org/10.1055/s-0040-1721499 |
Ejemplares similares
-
Safety of off‐label dose reduction of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2022) -
Managing the Increasing Burden of Atrial Fibrillation through Integrated Care in Primary Care: A Cost-Effectiveness Analysis
por: van den Dries, Carline J., et al.
Publicado: (2023) -
Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis
por: Joosten, Linda P T, et al.
Publicado: (2023) -
Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial
por: van den Dries, Carline J, et al.
Publicado: (2017) -
Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial
por: van den Dries, Carline J, et al.
Publicado: (2020)